Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China flag China · Delayed Price · Currency is CNY
9.16
+0.04 (0.44%)
Sep 4, 2026, 3:00 PM CST

SHA:600380 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
13,78115,08815,49216,52217,01315,747
Other Revenue
118.89127.26127.91124.63130.02157.06
13,90015,21615,61916,64617,14315,904
Revenue Growth
-9.05%-2.58%-6.17%-2.90%7.79%17.62%
Cost of Revenue
5,4825,7626,0996,6086,3805,778
Gross Profit
8,4199,4549,52110,03910,76310,126
Selling, General & Admin
4,4085,0214,8365,3685,9445,966
Research & Development
1,1731,2731,4351,6621,7421,397
Other Operating Expenses
228.54171.54155.49177.21196.72180.8
Operating Expenses
5,8066,4676,4317,2247,8857,553
Operating Income
2,6122,9873,0902,8152,8772,572
Interest Expense
-74.2-87.05-123.26-146.73-139.02-90.28
Interest & Investment Income
481.23540.83481.67611.73451.45263.85
Currency Exchange Gain (Loss)
-157.87-66.6822.8727.25104.46-2.74
Other Non Operating Income (Expenses)
-0.49-7.84-17.81-7.69-9.62-4.89
EBT Excluding Unusual Items
2,8613,3673,4533,3003,2852,738
Gain (Loss) on Sale of Investments
15.7719.49-17.5-25.42-76.26-23.51
Gain (Loss) on Sale of Assets
-0.672.9745.26-0.17-0.7124.04
Asset Writedown
-79.73-77.53-30.09-3.27-31.51-8.25
Other Unusual Items
98.1254.66123.81194.75280.06221.66
Pretax Income
2,8953,3663,5753,4663,4562,952
Income Tax Expense
427.05501.28592.14614.54561.8339.48
Earnings From Continuing Operations
2,4682,8652,9832,8512,8942,613
Minority Interest in Earnings
-1,269-1,529-1,596-1,408-1,392-1,284
Net Income
1,1981,3361,3871,4431,5031,328
Net Income to Common
1,1981,3361,3871,4431,5031,328
Net Income Growth
-14.11%-3.68%-3.90%-3.99%13.12%18.57%
Shares Outstanding (Basic)
1,8421,8301,8741,8981,8941,935
Shares Outstanding (Diluted)
1,8421,8301,8741,8981,8971,937
Shares Change
-1.08%-2.36%-1.30%0.07%-2.07%-0.97%
EPS (Basic)
0.650.730.740.760.790.69
EPS (Diluted)
0.650.730.740.760.790.69
EPS Growth
-13.17%-1.35%-2.63%-4.06%15.52%19.73%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,3863,1252,6572,7992,8301,042
Free Cash Flow Per Share
1.841.711.421.471.490.54
Dividend Per Share
0.2200.2200.2000.1800.1800.150
Dividend Growth
10.00%10.00%11.11%0%20.00%0%
Gross Margin
60.57%62.13%60.96%60.31%62.78%63.67%
Operating Margin
18.79%19.63%19.78%16.91%16.78%16.18%
Profit Margin
8.62%8.78%8.88%8.67%8.77%8.35%
Free Cash Flow Margin
24.36%20.54%17.01%16.81%16.51%6.55%
EBITDA
3,4023,7663,8743,8373,6833,167
EBITDA Margin
24.47%24.75%24.80%23.05%21.48%19.91%
D&A For EBITDA
789.25778.74784.371,022805.34594.45
EBIT
2,6122,9873,0902,8152,8772,572
EBIT Margin
18.79%19.63%19.78%16.91%16.78%16.18%
Effective Tax Rate
14.75%14.89%16.56%17.73%16.25%11.50%
Revenue as Reported
13,90015,21615,61916,64617,14315,904